PPP2R1B and colorectal cancer: Zhang et al. [11] show that miR-587-induced suppression of PPP2R1B triggers AKT activation (the downstream) to deliver an antiapoptotic signal, which weakens the efficiency of 5-FU-induced treatment and thereby brings about drug resistance in colorectal cancer cells.